Aug 6, 2026 06:57AM
Aug 5, 2026 04:01PM
Jul 29, 2026 06:30AM
Jul 29, 2026 06:30AM
Jul 27, 2026 06:49AM
Jul 24, 2026 06:35AM
Jul 24, 2026 06:35AM MannKind Announces $50 Million Private Placement
Jul 24, 2026 06:30AM
Jul 24, 2026 06:30AM
Jun 23, 2026 09:00AM
Jun 23, 2026 09:00AM
Jun 5, 2026 07:35PM
Jun 3, 2026 06:05AM
Jun 3, 2026 06:05AM MannKind Enters Data-Rich Development Period with Completion of Randomization in Phase 1b INFLO-1 Study and Enrollment of First Patient in Phase 2 INFLO-2 Trial for Nintedanib DPI in Patients with IPF
May 29, 2026 02:00PM
May 29, 2026 02:00PM
May 29, 2026 12:44PM
May 29, 2026 12:30PM
May 29, 2026 12:30PM
May 27, 2026 09:06AM
May 27, 2026 09:05AM MannKind to Showcase New Data at ADA 2026 Advancing Understanding of Inhaled Insulin (Afrezza®) in Pediatric Care, Pregnancy and Use with Automated Insulin Delivery (AID) Systems
May 6, 2026 06:31AM
May 6, 2026 06:30AM
Mar 9, 2026 09:05AM
Mar 9, 2026 09:05AM
Feb 26, 2026 08:00AM
Feb 9, 2026 06:10AM
Feb 9, 2026 06:05AM MannKind Announces First Patient Enrolled in INHALE-1ST Pediatric Study Evaluating Afrezza® for Youth with Newly-Diagnosed Type 1 Diabetes (T1D)
Jan 27, 2026 08:33AM
Jan 26, 2026 06:05AM
Jan 26, 2026 06:05AM
Jan 23, 2026 12:56PM
Jan 8, 2026 08:08AM
Jan 8, 2026 08:05AM
Dec 23, 2025 08:06AM MannKind gets FDA approval for FUROSCIX in pediatric patients
Dec 23, 2025 08:05AM
Dec 1, 2025 08:05AM
Dec 1, 2025 08:05AM
Nov 5, 2025 08:00AM
Oct 13, 2025 08:05AM
Oct 13, 2025 08:05AM
Sep 3, 2025 06:44AM MannKind (MNKD) PT Raised to $11 at H.C. Wainwright
Aug 27, 2025 08:06AM
Aug 27, 2025 08:05AM
Aug 25, 2025 07:30AM
Aug 25, 2025 07:30AM
Aug 6, 2025 07:05AM
May 8, 2025 08:05AM
Apr 12, 2025 04:00AM Biotech sector Q1 earnings preview from RBC Capital Markets
Mar 10, 2025 06:05AM

329,074 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All